The November 1st death of Daniel Best, a former pharmaceutical executive in charge of efforts to lower prescription drug prices for the US Department of Health and Human Services, has been ruled a suicide, according to the Washington D.C. Office of the Chief Medical Examiner, which noted that Best died of “multiple blunt force injuries,” according to Cleveland.com.
Headlines with a Voice 